Abbott Laboratories

Find Ratings Reports
ABT : NYSE : Health Care
$45.56 up 0.16 | 0.35%
Today's Range: 45.23 - 45.53
Avg. Daily Volume: 9248300.0
02/24/17 - 10:13 AM ET

Financial Analysis


ABBOTT LABORATORIES's gross profit margin for the fourth quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)5333.05188.0
EBITDA ($mil)0.01377.0
EBIT ($mil)948.0977.0
Net Income ($mil)798.0767.0


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)0.06125.0
Total Assets ($mil)0.041247.0
Total Debt ($mil)0.09001.0
Equity ($mil)0.021211.0


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin54.3863.11
EBITDA Margin0.026.54
Operating Margin17.7818.83
Sales Turnover0.00.49
Return on Assets0.010.72
Return on Equity0.012.28
Debt Q4 FY16 Q4 FY15
Current Ratio0.01.54
Debt/Capital0.00.3
Interest Expense0.041.0
Interest Coverage0.023.83


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)1472.311472.67
Div / share0.260.24
EPS0.510.46
Book value / share0.014.4
Institutional Own % n/a n/a
Avg Daily Volume9198527.09016181.0

Valuation


HOLD. ABBOTT LABORATORIES's P/E ratio indicates a significant premium compared to an average of 51.36 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 26.35. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ABT 62.25 Peers 51.36   ABT NA Peers 24.07

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

ABT is trading at a premium to its peers.

 

Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ABT 16.07 Peers 23.64   ABT 1.47 Peers 0.83

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ABT is trading at a discount to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ABT trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ABT NA Peers 5.03   ABT -58.73 Peers 96.88

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

Ratio not available.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ABT is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ABT 3.12 Peers 5.98   ABT 2.19 Peers 16.85

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ABT is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ABT significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades